CryoCell International Inc (CCEL)vsFresenius Medical Care Corporation (FMS)
CCEL
CryoCell International Inc
$3.99
-4.09%
HEALTHCARE · Cap: $35.48M
FMS
Fresenius Medical Care Corporation
$22.41
-0.40%
HEALTHCARE · Cap: $11.75B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 62311% more annual revenue ($19.43B vs $31.13M). FMS leads profitability with a 4.8% profit margin vs -7.9%. FMS appears more attractively valued with a PEG of 0.74. FMS earns a higher WallStSmart Score of 58/100 (C).
CCEL
Buy50
out of 100
Grade: C-
FMS
Buy58
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.9%
Fair Value
$5.05
Current Price
$3.99
$1.06 discount
Margin of Safety
+68.5%
Fair Value
$76.29
Current Price
$22.41
$53.88 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 129 in profit
Earnings expanding 72.1% YoY
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Areas to Watch
Smaller company, higher risk/reward
Revenue declined 1.9%
Distress zone — elevated risk
Currently unprofitable
1.4% revenue growth
Grey zone — moderate risk
ROE of 7.5% — below average capital efficiency
4.8% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : CCEL
The strongest argument for CCEL centers on Return on Equity, EPS Growth, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.74 suggests the stock is reasonably priced for its growth.
Bear Case : CCEL
The primary concerns for CCEL are Market Cap, Revenue Growth, Altman Z-Score.
Bear Case : FMS
The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
CCEL profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.83 — expect wider price swings.
FMS is growing revenue faster at 1.4% — sustainability is the question.
FMS generates stronger free cash flow (620M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (58/100 vs 50/100). CCEL offers better value entry with a 33.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CryoCell International Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?